ArticleDevelopment (Cambridge, England)2026
Feed-forward loops by NR5A2 ensure robust gene activation during pre-implantation development.
Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.International journal of cell biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Pioneer transcription factors are crucial for regulating zygotic genome activation and cell differentiation during mouse pre-implantation development. However, how pioneer factors function collectively to regulate early development remains poorly understood. Here, we determined the chromatin-binding profiles of the mouse pioneer factor NR5A2 during the totipotency-to-pluripotency transition and identified KLF and GATA family transcription factors as key co-regulators. NR5A2 regulates the expression of Klf5 and Gata6, the protein products of which in turn act as co-regulators of NR5A2 to promote development. Mechanistically, KLF5 contributes to H3K27ac deposition at genomic regions co-occupied by NR5A2. NR5A2 also regulates Xist expression, either directly or indirectly, through its role in co-binding with GATA factors and upregulating their expression. In vitro assays revealed that NR5A2 binds to nucleosomes with KLF5 and GATA6, suggesting that these pioneer factors can simultaneously bind to chromatin. Our findings provide evidence for a feed-forward regulatory mechanism by which NR5A2 activates expression of lineage-determining factors and these, together with NR5A2, subsequently co-bind nucleosomes to ensure robust gene activation during pre-implantation development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.